| Title |
PTEN modulators: a patent review
|
|---|---|
| Published in |
Expert Opinion on Therapeutic Patents, February 2013
|
| DOI | 10.1517/13543776.2013.768985 |
| Pubmed ID | |
| Authors | |
| Abstract |
PTEN (phosphatase and tensin homolog deleted on chromosome 10) plays a pivotal role in controlling intracellular signaling for cell survival and proliferation by inhibiting the PI3K/Akt pathway, and its dysfunction is associated with several neoplastic diseases. PTEN is frequently found mutated in many pathological conditions highlighting its importance in normal physiological function. Unlike several cellular proteins which are activated by phosphorylation, PTEN is inactivated upon phosphorylation by specific kinases which phosphorylate serine and threonine residues in its C-terminal region. Therefore, development of therapeutic agents that specifically target kinases and kinase-domain-containing proteins affecting PTEN would lead to the treatment of PTEN-related diseases. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 1% |
| Canada | 1 | 1% |
| Brunei Darussalam | 1 | 1% |
| Unknown | 92 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 24 | 25% |
| Student > Bachelor | 12 | 13% |
| Researcher | 12 | 13% |
| Student > Master | 8 | 8% |
| Professor | 5 | 5% |
| Other | 15 | 16% |
| Unknown | 19 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 19 | 20% |
| Medicine and Dentistry | 13 | 14% |
| Biochemistry, Genetics and Molecular Biology | 12 | 13% |
| Chemistry | 8 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 7% |
| Other | 16 | 17% |
| Unknown | 20 | 21% |